Skip to main content

Table 2 Cost inputs used in the model

From: Cost-effectiveness in unstable economies: the case of sacubitril/valsartan in heart failure with reduced ejection fraction in Argentina

input

Social security

Private

Source

Costs of primary therapy

 Monthly cost of sacubitril/valsartan

6028.38

6028.38

Novartis

 Monthly cost of enalapril

91.92

91.92

24

 Monthly cost of valsartan

390.78

390.78

24

Costs of background therapy (monthly cost)

 Beta blockers

194.59

194.59

24

 Mineralocorticoid receptor antagonists

234.97

234.97

24

 Digoxin

20.23

20.23

24

 Lipid lowering medications

305.17

305.17

24

 Diuretics

71.34

71.34

24

 Aspirin

19.21

19.21

24

 Anticoagulants

39.46

39.46

24

 ADP antagonists

315.69

315.69

24

Costs—HF Management (unit costs)

 GP emergency visits

2495.50

4073.24

30

 GP visits

464.81

873.17

30

 Cardiologist visits

841.46

1318.90

30

 Cost per hospitalisation

129,939.15

228,109.46

12

  1. Costs are expressed in Argentinan pesos (ARS). Exchange rate: 1USD = 89 ARS